Skip to main content
    D

    DocGo Inc (DCGO)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.19
    -0.02 (-8.53%)

    Market Cap: $20.55M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    DocGo Inc (DCGO) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    DocGo (DCGO) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, DocGo reported EPS of -$0.17, below the -$0.04 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    39%(7/18)
    Avg Surprise
    -47.78%

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.07
    Range-$0.08 - -$0.06
    7 analysts
    Revenue Consensus
    $79.17M
    Range$73.18M - $84.31M
    7 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.29
    Range-$0.37 - -$0.22
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.33+11.3%
    60d ago-$0.31+5.9%
    30d ago-$0.31+5.9%
    7d ago-$0.31+5.9%
    Current-$0.29
    Revenue Consensus
    $77.80M
    Range$73.91M - $80.64M
    3 analysts

    Next Report

    DCGO has an expected report date of Mar 15, 2027.

    DCGO Earnings Call

    The latest DCGO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 18 quarters below that had an estimate, DCGO beat 7 and missed 11. Revenue for the quarter ended Sep 30, 2026 was $73.43M, up 3.7% from $70.81M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.17-$0.04-$0.15 - -$0.02-325.00%MissN/A20 up, 1 downNov 9, 2026$73.43M
    Jun 30, 2026$0.16-$0.04N/A+500.00%BeatN/A20 up, 0 downAug 17, 2026$73.42M
    Mar 31, 2026-$0.33-$0.06-$0.22 - $0.10-450.00%MissN/A20 up, 0 downMay 11, 2026$75.55M
    Dec 31, 2025-$1.68-$0.14N/AN/AN/A-3511.4%20 up, 0 downMar 16, 2026$74.94M
    Sep 30, 2025-$0.25-$0.40-$0.40 - -$0.40+37.50%Beat-200.0%10 up, 1 downNov 10, 2025$70.81M
    Jun 30, 2025-$0.11-$0.06N/A-83.33%Miss-137.9%20 up, 1 downAug 7, 2025$80.42M
    Mar 31, 2025-$0.17$0.03-$0.07 - $0.14-666.67%Miss-136.2%20 up, 1 downMay 8, 2025$96.03M
    Dec 31, 2024$0.05$0.21$0.11 - $0.26-76.60%Miss-29.7%30 up, 2 downFeb 27, 2025$120.83M
    Sep 30, 2024$0.25$0.24N/A+4.17%Beat+8.7%70 up, 0 downNov 7, 2024$138.68M
    Jun 30, 2024$0.29$0.35N/A-17.14%Miss+383.3%60 up, 0 downAug 7, 2024$164.95M
    Mar 31, 2024$0.47$0.34N/A+38.24%Beat+487.5%70 up, 1 downMay 8, 2024$192.09M
    Dec 31, 2023$0.07$0.10$0.07 - $0.13-30.00%Miss+600.0%70 up, 0 downFeb 28, 2024$199.25M
    Sep 30, 2023$0.23$0.21N/A+9.52%Beat+91.7%60 up, 0 downNov 6, 2023$186.55M
    Jun 30, 2023$0.06$0.14N/A-57.14%Miss-87.8%60 up, 1 downAug 7, 2023$125.49M
    Mar 31, 2023$0.08$0.09N/A-11.11%Miss-78.9%60 up, 0 downMay 8, 2023$113.00M
    Dec 31, 2022$0.01$0.05$0.03 - $0.06-80.00%Miss-95.7%50 up, 0 downMar 13, 2023$108.78M
    Sep 30, 2022$0.12$0.17N/A-29.41%Miss-99.9%60 up, 0 downNov 7, 2022$104.32M
    Jun 30, 2022$0.49$0.13N/A+276.92%BeatN/A60 up, 0 downAug 8, 2022$109.52M
    Mar 31, 2022$0.38$0.19N/A+100.00%Beat+171.4%40 up, 0 downMay 9, 2022$117.89M
    Dec 31, 2021$0.23$0.02$0.01 - $0.03N/AN/AN/A40 up, 0 downMar 14, 2022$121.00M
    Sep 30, 2021$99.28$0.03N/AN/AN/AN/A11 up, 0 downNov 15, 2021$85.84M
    Jun 30, 2021-$0.04N/AN/AN/AN/AN/AN/AN/AAug 11, 2021$62.19M
    Mar 31, 2021$0.14N/AN/AN/AN/AN/AN/AN/AJun 3, 2021$49.69M
    Dec 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AMar 30, 2021$31.24M
    Sep 30, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/ANov 25, 2020$26.94M
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.21, after $1.06 the year before. It was -$0.01 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.21-308.5%
    Dec 31, 2024$1.06+140.7%
    Dec 31, 2023$0.44-56.0%
    Dec 31, 2022$1.00-99.0%
    Dec 31, 2021$99.61N/A
    Dec 31, 2020-$0.01N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,900 words across 9 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,9199
    2026Q2Jun 30, 20267,0757
    2026Q1Mar 31, 20266,2588
    2025Q4Dec 31, 20258,1439
    2025Q3Sep 30, 20256,9489
    2025Q2Jun 30, 20254,2366
    2025Q1Mar 31, 20257,1658
    2024Q4Dec 31, 20249,7579

    2026Q3 Earnings Call

    Opening remarks

    Mike Cole Vice President, Investor Relations Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements made in this conference call other than statements of historical fact are forward-looking statements. The words may, will, plan, potential, could, goal, outlook, design, anticipate, aim, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions may be used to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance, and we cannot assure you that we will achieve or realize our plans, intentions, outcomes, results, or expectations. Forward-looking statements are inherently subject to substantial risks, uncertainties, and assumptions, many of which are beyond our control and which may cause our actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in our forward-looking statements. These risks, uncertainties, and assumptions include, but are not limited to, those discussed in risk factors and elsewhere in DocGo's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release for this quarter, and other reports and statements filed by DocGo with the SEC, to which your attention is directed. Actual outcomes and results, or the timing of results or outcomes, may differ materially from what is expressed or implied by these forward-looking statements. In addition, today's call contains references to non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in our earnings release and the current report on Form 8-K that includes our earnings release, which is posted on our website, docgo.com, as well as filed with the SEC. The information contained in this call is accurate as of only the date discussed. Investors should not assume that statements will remain relevant and operative at a later time. We undertake no obligation to update any information discussed in this call to reflect events or circumstances after the date of this call, or to reflect new information or the occurrence of unanticipated events, except to the extent required by law. At this time, it is now my pleasure to turn the call over to Mr. Lee Bienstock, CEO of DocGo. Lee, please go ahead.

    Lee Bienstock CEO Thank you, Mike, and thank you all for joining us. We have a lot to cover on today's call. First, Norm and I will dive into the operational details, and then I'll discuss the CEO transition. Today, I'm pleased to report considerable progress on our path toward profitability.

    Frequently Asked Questions About DCGO

    When is DocGo's next earnings date?

    DocGo's next earnings report is expected for Mar 15, 2027.

    Did DCGO beat earnings estimates last quarter?

    No. DocGo reported EPS of -$0.17 for the quarter ended Sep 30, 2026, below the -$0.04 estimate by 325.00%.

    What EPS do analysts expect from DCGO next quarter?

    The consensus EPS estimate for DocGo for the quarter ending Dec 31, 2026 is -$0.07 from 7 analysts, with estimates from -$0.08 to -$0.06.

    How often does DCGO beat earnings estimates?

    DocGo beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -132.49%.